Lactose (India) Ltd.
BSE: 524202 | Sector: Health care |
NSE: N.A. | ISIN Code: INE058I01013 |
BSE 00:00 | 19 Jan | 24.00 |
-0.40 (-1.64%) |
OPEN
24.95 |
HIGH
26.50 |
LOW
23.55 |
NSE 05:30 | 01 Jan | Lactose (India) Ltd |
OPEN | 24.95 |
PREVIOUS CLOSE | 24.40 |
VOLUME | 9872 |
52-Week high | 29.60 |
52-Week low | 15.00 |
P/E | |
Mkt Cap.(Rs cr) | 24 |
Buy Price | 24.00 |
Buy Qty | 303.00 |
Sell Price | 24.45 |
Sell Qty | 61.00 |
Lactose (India) Ltd. (LACTOSEINDIA) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 596.25 | 2.55 | 627.95 | 315.20 | 143058.26 |
Divi's Lab. | 3601.30 | 1.03 | 3913.00 | 1632.70 | 95596.51 |
Dr Reddy's Labs | 5086.95 | 0.68 | 5514.65 | 2497.60 | 84595.98 |
Cipla | 822.35 | 2.63 | 869.65 | 356.75 | 66318.41 |
Biocon | 451.70 | 0.55 | 487.70 | 235.80 | 54204.00 |
Aurobindo Pharma | 923.75 | 0.81 | 996.65 | 281.15 | 54122.51 |
Cadila Health. | 485.40 | 2.64 | 509.35 | 212.70 | 49690.40 |
Lupin | 1090.15 | 2.54 | 1121.85 | 505.00 | 49438.30 |
Torrent Pharma. | 2750.50 | 4.32 | 3040.00 | 1619.00 | 46543.96 |
Gland Pharma | 2287.70 | -1.78 | 2509.05 | 1701.00 | 37358.14 |
Apollo Hospitals | 2646.40 | 1.51 | 2657.35 | 1047.45 | 36816.72 |
Alkem Lab | 3053.50 | 0.25 | 3150.00 | 1950.00 | 36504.59 |
Piramal Enterp. | 1590.45 | 0.44 | 1727.60 | 608.00 | 35872.60 |
Abbott India | 14605.95 | -1.03 | 18569.00 | 12218.10 | 31037.64 |
Ipca Labs. | 2123.75 | -0.35 | 2455.55 | 1162.00 | 26939.77 |
Glaxosmi. Pharma | 1540.60 | 0.76 | 1805.00 | 1046.40 | 26099.31 |
Syngene Intl. | 599.05 | 2.22 | 644.65 | 201.65 | 23962.00 |
Pfizer | 4963.85 | 0.38 | 5875.00 | 3588.15 | 22709.61 |
Alembic Pharma | 1029.90 | -3.76 | 1150.00 | 436.10 | 20242.69 |
Laurus Labs | 363.05 | 2.01 | 377.30 | 61.90 | 19481.26 |
Quick Links for Lactose (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices